Impact of umbilical cord blood-derived mesenchymal stem cells on cardiovascular research

Santiago Roura, Josep Maria Pujal, Carolina Gálvez-Montón, Antoni Bayes-Genis

Research output: Contribution to journalReview articleResearchpeer-review

7 Citations (Scopus)


© 2015 Santiago Roura et al. Over the years, cell therapy has become an exciting opportunity to treat human diseases. Early enthusiasm using adult stem cell sources has been tempered in light of preliminary benefits in patients. Considerable efforts have been dedicated, therefore, to explore alternative cells such as those extracted from umbilical cord blood (UCB). In line, UCB banking has become a popular possibility to preserve potentially life-saving cells that are usually discarded after birth, and the number of UCB banks has grown worldwide. Thus, a brief overview on the categories of UCB banks as well as the properties, challenges, and impact of UCB-derived mesenchymal stem cells (MSCs) on the area of cardiovascular research is presented. Taken together, the experience recounted here shows that UCBMSCs are envisioned as attractive therapeutic candidates against human disorders arising and/or progressing with vascular deficit.
Original languageEnglish
Article number975302
JournalBioMed Research International
Publication statusPublished - 1 Jan 2015


Dive into the research topics of 'Impact of umbilical cord blood-derived mesenchymal stem cells on cardiovascular research'. Together they form a unique fingerprint.

Cite this